| 1990 |
HPR1 encodes a novel 752-amino acid protein with C-terminal homology to yeast topoisomerase I (TOP1); hpr1 null mutants show extremely high rates of intrachromosomal excision recombination, and hpr1 top1 double mutants grow very poorly, indicating functional interaction with Top1. |
Complementation cloning, sequence analysis, genetic double-mutant analysis |
Molecular and cellular biology |
Medium |
2181275
|
| 1996 |
Mutations in RNA polymerase II components RPB2 and transcription initiation factor SUA7 (TFIIB) suppress hpr1 hyperrecombination, establishing by genetic epistasis that Hpr1 functions in the RNA polymerase II transcription machinery. |
Suppressor genetics, cloning, sequencing of soh (suppressor of hpr1) mutants |
Genetics |
Medium |
8849885
|
| 1997 |
Hpr1 is required for transcriptional elongation; hpr1Δ cells cannot elongate transcription through the bacterial lacZ coding region (a long G+C-rich sequence) but elongate through yeast PHO5 normally; elongation defects are associated with hyperrecombination and genomic instability. |
Northern blot, primer extension, 6-azauracil sensitivity, lacZ reporter assays |
Genes & development |
High |
9407037
|
| 2000 |
Hpr1 forms a stable nuclear oligomeric protein complex (the THO complex) with Tho2, Mft1, and a novel protein Thp2; reciprocal immunoprecipitation using HA-tagged Tho2 and anti-Mft1 antibodies confirmed the four-subunit complex; mft1Δ and thp2Δ cells phenocopy hpr1Δ with mitotic hyperrecombination and impaired transcription elongation. |
Affinity purification (His6-HA-tagged Tho2), reciprocal immunoprecipitation with anti-Mft1 antibodies, genetic phenotyping |
The EMBO journal |
High |
11060033
|
| 2001 |
Hpr1 (as part of the THO complex) is preferentially required for transcription of long DNA sequences and G+C-rich sequences; the negative effect of sequences on transcription depends on distance from the promoter, and hyperrecombination correlates with transcriptional defects. |
GAL1-driven reporter assays with varying lacZ segments, LYS2 and YAT1 sequences; Northern blot; recombination assays |
Molecular and cellular biology |
Medium |
11564888
|
| 2001 |
High-copy SUB2 (yeast homolog of human splicing factor UAP56/hUAP56) suppresses hpr1Δ genomic instability, and high-copy HPR1 suppresses sub2 conditional mutant instability; this bidirectional epistasis links Hpr1 to the RNA helicase Sub2 in a common pathway controlling genome stability. |
High-copy suppressor genetics, conditional allele analysis, reciprocal suppression |
Molecular and cellular biology |
Medium |
11463828
|
| 2002 |
Deletion of HPR1 or THO2 impairs transcription-coupled nucleotide excision repair (TCR) as shown by T4 endonuclease V analysis of RPB2 transcribed strand repair; modest effects on global genome repair (GGR) also observed, indicating the THO complex contributes to both NER pathways. |
UV sensitivity assays, T4 endo V strand-specific repair analysis |
Nucleic acids research |
Medium |
12000839
|
| 2005 |
Yeast Hpr1 is ubiquitylated by the HECT E3 ubiquitin ligase Rsp5 (with Ubc4 as the conjugating enzyme); Hpr1 degradation is enhanced at high temperature and is linked to ongoing RNA Pol II–mediated transcription; this ubiquitin-mediated turnover is specific to Hpr1 among THO subunits, suggesting Hpr1 ubiquitylation controls THO/TREX complex formation and mRNA export. |
In vivo ubiquitylation assays, in vitro ubiquitylation reconstitution with purified components, co-immunoprecipitation, genetic analysis |
The Journal of biological chemistry |
High |
15713680
|
| 2005 |
Human hHpr1/p84/Thoc1 associates with elongating (hyperphosphorylated) RNA polymerase II and with the RNA splicing/export factor UAP56 in intact cells; depletion of hHpr1/p84/Thoc1 causes transcriptional elongation defects, establishing that the human protein physically links elongating RNA Pol II with RNA processing factors in a TREX-like complex. |
Co-immunoprecipitation from cell extracts, RNAi-mediated depletion, transcription elongation assays |
Molecular and cellular biology |
High |
15870275
|
| 2006 |
Homozygous null Thoc1 mice are not viable; embryonic development arrests around implantation with blastocyst hatching and outgrowth defects; inner cell mass cells are especially dependent on Thoc1, demonstrating that the mammalian ortholog is essential for early embryonic development. |
Mouse knockout generation, embryo culture, in vitro blastocyst outgrowth assays |
Molecular and cellular biology |
High |
16705185
|
| 2006 |
The hpr1-101 point mutant shows strong transcription defects and general mRNA export defects without triggering hyperrecombination or retarding replication fork progression, demonstrating that mRNP biogenesis impairment and transcription-associated recombination can be mechanistically uncoupled. |
Site-directed mutagenesis, Northern blot, in situ hybridization for mRNA export, 2D gel electrophoresis for replication fork analysis |
Molecular and cellular biology |
Medium |
16908536
|
| 2007 |
The ubiquitin-associated (UBA) domain of mRNA export receptor Mex67 directly interacts with Hpr1; deletion or mutation of helix H4 of UBA-Mex67 decreases Hpr1-binding affinity but strengthens ubiquitin binding; Hpr1 interaction is required for UBA-Mex67 to bind polyubiquitin; in vivo, H4 deletion reduces cotranscriptional Mex67 recruitment to active genes and impairs mRNA export. |
Structural NMR of UBA domain, binding affinity measurements, in vivo chromatin immunoprecipitation, mRNA export assays |
Molecular biology of the cell |
High |
17475778
|
| 2007 |
Depletion of human Thoc1 protein (pThoc1) causes apoptotic cell death specifically in neoplastically transformed cells, coincident with increased DNA damage (phospho-H2AX); normal cells are largely unaffected; normal cells lacking Thoc1 cannot be transformed by E1A and Ha-ras, implicating Thoc1 in neoplastic transformation. |
RNAi depletion in isogenic normal vs. oncogene-transformed cell lines, apoptosis assays, γH2AX immunostaining, transformation assay |
Cancer research |
Medium |
17638875
|
| 2009 |
The hpr1-101 mutant impairs transcription and mRNP biogenesis without causing accumulation of co-transcriptional R-loops; AID-induced mutations in hpr1-101 occur at equal frequency on both DNA strands (unlike hpr1Δ where ssDNA from R-loops is the AID target), demonstrating that THO has an R-loop-independent transcriptional function. |
AID-induced mutation/recombination assays, strand-specific mutational analysis |
Nucleic acids research |
Medium |
19451165
|
| 2009 |
NMR solution structure of the Mex67 UBA domain complexed with an FXFG nucleoporin peptide shows that Hpr1 and FG-repeat nucleoporins bind to overlapping sites on UBA-Mex67; Hpr1 binding allows UBA-Mex67 to interact with tetra-ubiquitin, whereas FXFG binding prevents mono- or tetra-ubiquitin binding. |
NMR solution structure determination, fluorescence resonance energy transfer (FRET)-based binding assays, NMR titration |
The Journal of biological chemistry |
High |
19401465
|
| 2013 |
Human Thoc1 protein is poly-ubiquitinated by the NEDD4-1 E3 ubiquitin ligase and subsequently degraded by the proteasome; destabilization of Thoc1 upon transcriptional elongation inhibitor treatment is dependent on NEDD4-1, indicating evolutionary conservation of ubiquitin-mediated THO regulation between yeast (Rsp5) and mammals. |
In vitro ubiquitylation reconstitution with purified components, manipulation of NEDD4-1 levels in cells, proteasome inhibitor experiments |
PloS one |
High |
23460917
|
| 2013 |
In cancer cells, nitric oxide (NO) produced by activated macrophages suppresses THOC1 expression via the Nrf2 transcription factor acting on an antioxidant response element (ARE) in the THOC1 promoter; overexpression of Thoc1 confers resistance to NO-mediated cytotoxicity; Thoc1 downregulation leads to Bcl-2 downregulation and apoptosis. |
Co-culture experiments, iNOS inhibitor, NO donor treatment, promoter-reporter assays, ARE mutagenesis, Nrf2 overexpression/knockdown |
Biochemical pharmacology |
Medium |
23688498
|
| 2014 |
Conditional deletion of Thoc1 in the mouse hematopoietic system reveals that granulocyte-macrophage progenitors have a cell-autonomous requirement for Thoc1 to maintain growth and viability, while lymphoid lineages are not detectably affected under homeostatic conditions. |
Inducible conditional knockout mouse, bone marrow reconstitution, flow cytometry of hematopoietic lineages |
PloS one |
Medium |
24830368
|
| 2014 |
Conditional deletion of Thoc1 in an autochthonous mouse prostate cancer model prevents cancer progression but has little effect on normal prostate tissue; prostate cancer cells deprived of Thoc1 show gene expression defects that compromise cell growth. |
Conditional knockout mouse in TRAMP prostate cancer model, histopathology, gene expression analysis |
Journal of the National Cancer Institute |
Medium |
25296641
|
| 2016 |
Thoc1 deficiency in Rb1-null mice delays embryo death and reduces apoptosis in the brain; E2f protein levels and expression of E2f-regulated apoptotic genes (Apaf1, Bak1) are reduced in Rb1:Thoc1-deficient brain tissue, indicating that Thoc1 supports elevated E2f expression and downstream apoptotic gene expression triggered by Rb1 loss. |
Compound conditional knockout mouse, immunohistochemistry, Western blot, qRT-PCR of apoptotic gene expression |
Molecular and cellular biology |
Medium |
27001308
|
| 2020 |
THOC1 knockdown leads to R-loop formation and DNA damage in hepatocellular carcinoma cells; THOC1 promotes G2/M cell cycle transition and HCC cell proliferation in vitro and in vivo. |
shRNA knockdown, R-loop immunofluorescence, γH2AX assay, colony formation, cell cycle analysis, xenograft mouse model |
Journal of experimental & clinical cancer research |
Medium |
32669125
|
| 2020 |
THOC1 deficiency causes hair cell apoptosis via the p53 signaling pathway; in zebrafish, thoc1 knockout reduces hair cell numbers, and depletion of p53 or treatment with the p53 inhibitor Pifithrin-α significantly rescues hair cell loss; transcriptome sequencing showed upregulation of p53-associated genes in thoc1 mutants. |
CRISPR-Cas9 knockout zebrafish, morpholino knockdown, mRNA rescue injection, RNA sequencing, p53 inhibitor treatment, hair cell counting |
PLoS genetics |
High |
32776944
|
| 2022 |
Thoc1 promotes cancer stem cell characteristics in triple-negative breast cancer by facilitating mRNA export of stemness-related genes; knockdown reduces cancer stem cell populations and mammosphere formation; overexpression of Thoc1 promotes TNBC malignancy; andrographolide reduces Thoc1 expression through suppression of NF-κB, an upstream transcriptional regulator of Thoc1. |
shRNA knockdown, overexpression, mammosphere assay, mRNA export assay, orthotopic mouse model, NF-κB reporter assay |
Biochemical pharmacology |
Medium |
36330949
|
| 2024 |
THOC1 interacts with SIN3A (a histone deacetylase complex component); THOC1 knockdown leads to elevated R-loop levels, reduced histone deacetylation, increased telomeric R-loops, and shortened telomeres in glioblastoma cells. |
CRISPR knockout screen, co-immunoprecipitation, R-loop immunofluorescence, telomere length analysis, RNA sequencing |
Neoplasia (New York, N.Y.) |
Medium |
41496272
|
| 2025 |
THOC1 directly binds U2AF2 (U2 snRNA auxiliary factor 2) via its THOC1-340S interaction site; this interaction regulates U2AF2 expression and mediates suppression of Wnt/β-catenin signaling, as evidenced by changes in cyclinD1, c-Myc, and β-catenin protein levels in ovarian cancer cells. |
Immunoprecipitation, GST pull-down, immunofluorescence, RNA sequencing, KEGG pathway analysis |
Cancer cell international |
Medium |
41372894
|
| 2025 |
In Δhpr1 yeast cells, Nab2, Yra1 and Mex67 levels are increased in nuclear mRNPs; overexpression of Nab2 or Yra1 in Δhpr1 cells suppresses the mRNA export defect and reduces Mex67 levels in nuclear mRNPs to wild-type levels, indicating that Hpr1 regulates the amount of Mex67 loaded onto nuclear mRNPs and that excess Mex67 in mRNPs impairs nuclear mRNA export. |
RNA immunoprecipitation, mRNA export assays, genetic overexpression experiments in Δhpr1 cells |
bioRxivpreprint |
Medium |
bio_10.1101_2025.02.26.640412
|